LEO, Eliana Grazia
 Distribuzione geografica
Continente #
NA - Nord America 10.276
EU - Europa 5.834
AS - Asia 1.293
SA - Sud America 38
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 10
Totale 17.497
Nazione #
US - Stati Uniti d'America 10.225
GB - Regno Unito 2.172
IT - Italia 1.200
SE - Svezia 820
DE - Germania 507
CN - Cina 502
UA - Ucraina 330
HK - Hong Kong 262
TR - Turchia 246
FI - Finlandia 210
FR - Francia 177
BG - Bulgaria 140
BE - Belgio 115
IN - India 85
CA - Canada 43
KR - Corea 38
SG - Singapore 37
IE - Irlanda 36
IR - Iran 28
AU - Australia 25
BR - Brasile 23
JP - Giappone 20
RU - Federazione Russa 20
RO - Romania 19
MY - Malesia 16
CH - Svizzera 15
NL - Olanda 14
ES - Italia 11
ID - Indonesia 11
EU - Europa 10
NZ - Nuova Zelanda 10
TW - Taiwan 10
PH - Filippine 9
PT - Portogallo 9
CL - Cile 8
EG - Egitto 7
PK - Pakistan 7
PA - Panama 6
PL - Polonia 6
VN - Vietnam 6
CO - Colombia 5
CZ - Repubblica Ceca 5
IL - Israele 5
AT - Austria 4
DK - Danimarca 4
GR - Grecia 4
HU - Ungheria 4
LT - Lituania 4
RS - Serbia 4
IQ - Iraq 3
TH - Thailandia 3
HR - Croazia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
CY - Cipro 1
JO - Giordania 1
MA - Marocco 1
MC - Monaco 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
SN - Senegal 1
Totale 17.497
Città #
Southend 1.754
Fairfield 1.242
Chandler 1.067
Woodbridge 944
Jacksonville 705
Ashburn 684
Houston 665
Dearborn 572
Nyköping 523
Ann Arbor 521
Wilmington 484
Seattle 452
Cambridge 427
Hong Kong 257
Modena 241
Beijing 188
Izmir 150
Princeton 149
Sofia 137
Eugene 126
San Diego 118
Brussels 102
Helsinki 99
Bremen 94
New York 83
Redwood City 73
Milan 66
Fremont 61
Des Moines 49
London 49
Rome 40
Shanghai 33
Dublin 31
Falls Church 31
Frankfurt am Main 31
Ottawa 31
Bologna 28
Nanjing 27
Boardman 24
Hefei 24
San Mateo 22
Napoli 20
Leawood 16
Kunming 15
Los Angeles 15
Parma 15
Augusta 14
Norwalk 14
Reggio Nell'emilia 14
Tulare 14
Hounslow 13
Xian 13
Carmichael 12
Guangzhou 12
Jinan 12
Sydney 12
Gurgaon 11
Philadelphia 11
Auburn Hills 10
Belfast 10
Chiswick 10
Mountain View 10
Verona 10
Formigine 9
Fuzhou 9
Vailate 9
Manila 8
Mumbai 8
Naples 8
Pontinia 8
Reggio Emilia 8
San Francisco 8
Torino 8
Ardabil 7
Bari 7
Catania 7
Centrale 7
Ferrara 7
Hangzhou 7
Kilburn 7
Messina 7
Monmouth Junction 7
New Delhi 7
Seoul 7
Tokyo 7
College Park 6
Dallas 6
Deford 6
Gunzenhausen 6
Hebei 6
Indiana 6
Panama City 6
Prescot 6
Scauri 6
Toronto 6
Villasanta 6
Wuhan 6
Bomporto 5
Chicago 5
Dong Ket 5
Totale 12.941
Nome #
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant 309
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery 251
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis 228
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 221
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 220
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 214
Organo-modified bentonite for gentamicin topical application: interlayer structure and in vivo skin permeation 211
Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection 210
Characterization of natural clays from italian deposits with focus on elemental composition and exchange estimated by edx analysis: potential pharmaceutical and cosmetic uses 199
Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy 197
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector 195
Polymeric and Solid Lipid Nanoparticles for nose-to-brain delivery of geraniolursodeoxycholic acid conjugate: development and characterization studies 195
Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier 192
Application of the "in-oil nanoprecipitation" method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 191
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 186
In vivo penetration of bare and lipid-coated silica nanoparticles across the human stratum corneum 185
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 184
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 184
Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes 184
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 183
Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability 179
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 178
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 178
Chitosan-alginate microparticles as a protein carrier 176
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. 175
Bead coating process via an excess of crosslinking agent 173
Vettori particellari per il rilascio sito-specifico di farmaci nel tratto gastro-intestinale 168
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 167
Protein immobilization in crosslinked alginate microparticles 166
Anti-TB inhalation therapy: Design of mannose-based functionalised Solid Lipid Microparticles for an active targeting to alveolar macrophages 165
In vivo silica nanoparticle translocation across human stratum corneum: the effect of surface hydrophobization in relation to hair follicle density. 165
Self-assembled organogelators as artificial stratum corneum models: key-role parameters for skin permeation prediction 164
Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process 163
In vivo detection of lipid-based nano- and microparticles in the outermost human stratum corneum by EDX analysis 161
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 161
Studio reologico del complesso alginato/chitosano/albumina per la preparazione di microsfere 160
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles. 157
In vitro behaviour of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin 156
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation 154
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 152
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 151
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 148
Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates 148
Oral tolerance elicited in mice by b-lactoglobulin entrapped in biodegradable microspheres. 147
In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form 146
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy 146
Novel engineered lipid-based nanoparticles for pulmonary tuberculosis inhalation therapy 146
DEVELOPMENT AND COMPARISON OF TWO LIPID-BASED NANOSYSTEMS FOR THE CO-DELIVERY OF RIFAMPICIN AND ISONIAZID: SMALL-ANGLE NEUTRON SCATTERING CHARACTERISATION 145
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 145
Self-assembling organogelators for artificial stratum corneum models: key-role parameters in skin permeation prediction 142
SOLID LIPID MICROPARTICLES FOR INHALED ANTI-TB THERAPY BY DPI: INFLUENCE OF THE PRODUCTION PROCESS ON DRUG STABILITY AND POWDER BREATHABILITY 141
Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation 140
Small-angle neutron scattering characterization of liposomes for anti-tuberculosis inhaled therapy. 138
Lipid-based microparticles for TB inhaled therapy: physical properties and cell internalization 137
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 137
PROGETTAZIONE E OTTIMIZZAZIONE DI SISTEMI MICROPARTICELLARI PER LA VEICOLAZIONE AI MACROFAGI ALVEOLARI DI FARMACI ANTITUBERCOLARI PER VIA INALATORIA 135
Surface drug removal from ibuprofen-loaded PLA microspheres 133
Formulazione e caratterizzazione di nanoparticelle polimeriche per la somministrazione orale di eparina 133
Nanoencapsulation of an hTS inhibitor octapeptide against ovarian cancer in solid lipid matrix 133
Cell internalization study of hybrid chitosan-heparin-PLGA nanocarriers on Caco-2 cells 132
In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? 130
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method 129
Veicolazione intracellualre di DNA plasmidico mediante solid lipid nanoparticles (SLN) cationiche 125
Development of lipid nanocarriers as delivery systems for a small peptide with anti-ovarian activity 125
Metodo per modulare l'assorbimento fagocitario di un principio attivo o un suo precursore da parte di macrofagi 125
In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time 124
Preparation and characterization of biodegradable nanoparticles containing a lipophilic drug in water-soluble or insoluble form 123
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 122
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 121
Drug release from perforated matrices containing hydroxypropylcellulose 121
Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates 121
Formulazione per veicolare principi attivi lipofili 120
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 119
PLA-microparticles formulated by means a thermoreversible gel able to modify protein encapsulation and release without being co-encapsulated 117
In vivo fate and immune pulmonary response after nasal administration of microspheres loaded with phosphorylcholine-thyroglobulin 116
In vitro behaviour of N6-cyclopentyladenosine-loaded nanoparticles prepared via a non-aqueous nanoprecipitation method 114
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 113
Inhaled SLM for anti-TB therapy by DPI device: process parameters affecting freeze-drying and breathability 113
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 112
Ovuli vaginali a rilascio prolungato come inquinanti in pap-test 111
Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight 110
Sistemi lipidici per il transfer genico: sintesi di nuove molecole per la progettazione di vettori sintetici efficaci 109
Cationic solid lipid nanoparticles containing Protamine as transfection vector on neuroblastoma cell line 109
SURFACE ENGINEERING OF SOLID LIPID NANOASSEMBLIES FOR INHALED INTRAMACROPHAGIC ANTI-TB THERAPY 109
Tetracycline-Montmorillonite nanoclay for the treatment of H. pylori infection 109
In vitro evaluation on CaCo-2 cells of hybrid lipid/chitosan nanoparticles for the oral delivery of heparin. 108
Modified PLGA Nanoparticles as drug carriers for CNS delivery 105
The role of protamine in the gene delivery by cationic SLN on different cell lines 105
Development and in vitro characterization of SLN encapsulating magnetic Heparin coated Iron Oxide for theranostic application 105
Studio della fotodegradazione di un complesso PABA/alginato per la formulazione di filtri solari 103
Caratterizzazione chimico-fisica di membrane e feltri di collagene 102
Drug delivery strategies of Geraniol via nose-to-brain for the treatment of neuronal disorders 102
The improvement of Solid Lipid Microparticle breathability for an anti-TB inhalation therapy 101
Inhalated drug delivery systems to target alveolar macrophages for tuberculosis therapy: design of safe SLM loaded with rifampicin 98
The effect of triglycerid/phospholipid ratio in liposphere preparation 97
Nuove molecole funzionalizzanti per il targeting ai macrofagi di vettori lipidici 96
Medicinal Chemistry drives drug targeted delivery: a successful interplay 96
Chitosan/heparin polyelectrolyte complexes as ion-paring approach to encapsulate heparin in orally administrable SLN: In vitro evaluation 96
Solid Lipid Microparticles for inhaled anti-TB therapy by DPI: influence of the production process on drug stability and powder breathability 95
Characterization of cationic SLN/protamine complex as a non-viral transfer vector 94
Totale 14.730
Categoria #
all - tutte 58.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.084


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.172 0 0 0 0 0 0 0 0 147 247 412 366
2019/20203.614 272 180 133 219 430 514 608 385 347 145 212 169
2020/20213.105 441 198 237 220 260 190 253 310 160 436 292 108
2021/20222.585 63 304 233 158 86 174 125 134 314 196 510 288
2022/20233.026 464 350 212 326 337 419 66 245 343 55 120 89
2023/20241.445 89 126 139 176 362 183 165 162 43 0 0 0
Totale 17.772